[Retracted] Clinical Study of Anti-PD-1 Immunotherapy Combined with Gemcitabine Chemotherapy in Multiline Treatment of Advanced Pancreatic Cancer

Figure 1

Survival curve of sintilimab immunotherapy regimen.